There is a crisis of confidence in one of the most widely used psychiatric drugs, selective serotonin (5-HT) re-uptake inhibitors (SSRIs). Thought to boost synaptic levels of 5-HT by blocking its re-absorption from the synaptic cleft via the 5-HT re-uptake transporter (SERT), SSRIs were widely touted as the most effective treatment for depression in mature patients. Recent reports show that SSRI exposure during key developmental stages may increase the risk of depression and suicide in both mice and humans (1,2). In fact, even in adults some studies suggest a twofold increase in the rate of suicide attempts in patients receiving SSRIs compared with placebo or therapeutic interventions other than tricyclic antidepressants (3). Despite such misgivings the genetic basis and molecular mechanisms of the most widely used antidepressant in history Prozac (fluoxetine) remain largely unknown. Fluoxetine and 5-HT both stimulate egg-laying in C. elegans. Fluoxetines action is both 5-HT dependent and independent, it can still induce, at least partially, egg-laying in both 5-HT (
tph-1 (
mg280)) and SERT (
mod-5 (
n3314)) deficient animals. To distinguish the action of 5-HT from that of fluoxetine we are conducting a genetic screen for resistance to fluoxetine stimulation of egg-laying in a
ser-1 (
ok345) mutant background. SER-1 is a G-protein coupled receptor expressed in the vulval muscles; mutants lacking this gene are fully resistant to 5-HT stimulated egg-laying but respond substantially to fluoxetine (4). F2 progeny of ethylmethane sulfonate mutagenized animals are exposed to 0.5 mg/ml fluoxetine and resistant animals who lay no eggs are recovered. Egg-laying can also be stimulated by the tricyclic antidepressant imipramine via a different genetic pathway which includes the 5-HT receptor SER-4 (4). To select specifically fluoxetine resistant mutants, we compare egg-laying rates of mutants in fluoxetine and imipramine, animals capable of laying eggs in the presence of imipramine but not fluoxetine are studied further. 1. Whittington, C. J., Kendall, T., Fonagy, P., Cottrell, D., Cotgrove, A. & Boddington, E.(2004) Lancet 363, 1341-1345. 2. Ansorge, M. S., Zhou, M. M., Lira, A., Hen, R. & Gingrich, J. A. (2004) Science 306, 879-881.3. Fergusson, D., Doucette, S., Cranley, K., Glass, K. C., Shapiro, S., Healy, D., Hebert, P. & Hutton, B. (2005) British Medical Journal 330, 396-399.4. Dempsey, C. M. Mackenzie S. M., Gargus A., Blanco G. & Sze J. Y. (2005). 5-HT (5HT), Genetics (In press)